Company Profiles

driven by the PitchBook Platform

BioTheranostics

Description

Developer of predictive tests for cancer treatment. The company discovers, develops, and commercializes proprietary molecular-based diagnostic, prognostic, and predictive tests that provide physicians with actionable information to help guide cancer treatment

1996

Founded

PRIVATE

Status

51-200

Employees

Later Stage VC

Latest Deal Type

$32M

Latest Deal Amount

$8M

Total Amount Raised

Description

Developer of predictive tests for cancer treatment. The company discovers, develops, and commercializes proprietary molecular-based diagnostic, prognostic, and predictive tests that provide physicians with actionable information to help guide cancer treatment

Website:

www.biotheranostics.com

Formerly Known As

AviaraDX, SDL Acquisition

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Diagnostic Equipment

Primary Office

9640 Towne Centre Drive Suite 200 San Diego, CA 92121United States +1 (877) 886-6739
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore BioTheranostics's full profile, request a free trial.

BioTheranostics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

BioTheranostics Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

BioTheranostics Investors (3)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Canepa Advanced Healthcare FundOtherMinority000 0000000 0000
HealthQuest CapitalVenture CapitalMinority000 0000000 0000
MVM Life Science PartnersVenture CapitalMinority000 0000000 0000
Canepa Advanced Healthcare Fund Other
HealthQuest Capital Venture Capital
MVM Life Science Partners Venture Capital

BioTheranostics Executive Team (7)

NameTitleBoard
Seat
Contact
Info
Nicolas BarthelemyPresident & Board Member, Chief Executive Officer
Gail SloanChief Financial Officer
Andy LavagninoContract Controller
Catherine SchnabelChief Scientific Officer
Jen Skeen Ph.DVice President, Clinical Operations
Nicolas Barthelemy President & Board Member, Chief Executive Officer
Gail Sloan Chief Financial Officer
Andy Lavagnino Contract Controller
Catherine Schnabel Chief Scientific Officer
Jen Skeen Ph.D Vice President, Clinical Operations

BioTheranostics Board Members (6)

NameRepresentingRoleSinceContact
Info
Alejandro SanchezCanepa Advanced Healthcare FundBoard Member000 0000
Brad SmithSelfBoard Member000 0000
Brian ArmstrongBioMérieuxBoard Member000 0000
David Kabakoff Ph.DHealthQuest CapitalBoard Member000 0000
Eric Bednarski Ph.DBioTheranosticsBoard Member000 0000
Alejandro Sanchez Board Member Canepa Advanced Healthcare Fund
Brad Smith Board Member Self
Brian Armstrong Board Member BioMérieux
David Kabakoff Ph.D Board Member HealthQuest Capital
Eric Bednarski Ph.D Board Member BioTheranostics
Request full access to PitchBook